Skip to content

A prospective, open, randomized controlled, multicenter clinical study of antibiotic texture containing HS21C01 for preventing hospital-based cross infection

A prospective, open, randomized controlled, multicenter clinical study of antibiotic texture containing HS21C01 for preventing hospital-based cross infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092546
Enrollment
Unknown
Registered
2024-11-19
Start date
2024-11-19
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospital-acquired infections are infections acquired by hospitalized patients in hospitals including infections that occur during hospitalization and infections that occur after discharge from hospitals

Interventions

Control group (Group B):Use of hospital gowns, sheets, duvet covers, pillowcases and towels made of ordinary fabrics in hospitals
Test group (Group A):Gowns, sheets, covers, pillowcases, towels made of antimicrobial fabrics containing HS21C01

Sponsors

South China Hospital of Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients admitted to ICU, hematology department, oncology department and other departments for non-infectious reasons; 18= age =70 years; 2.Voluntary consent to participate in the study was obtained by signing an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Allergic reactions or other adverse reactions to antibacterial fabrics containing HS21C01; 2.Unable to complete all the tests and treatments required for the study; 3.Have a mental illness or cognitive impairment that prevents them from cooperating with the study; 4.Concurrent participation in other intervention studies; 5.Those with a history of antimicrobial drug abuse; 6.Focal points of infection were present prior to admission; 7.Other exclusion criteria set by the study were not met; 8.Consider evidence of multidrug-resistant bacteria colonizing the patient upon admission.

Design outcomes

Primary

MeasureTime frame
Clinically effective;Unevaluable;Clinically ineffective;

Countries

China

Contacts

Public ContactNan Liu

South China Hospital of Shenzhen University

13688869875@163.com+86 755 21583851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026